EDEN PRAIRIE, Minn., May 3, 2023 /PRNewswire/ — MIVI Neuroscience, Inc., innovator of next-generation neurointerventional medical devices, today announced that it has completed enrollment in the company’s clinical trial to assess the safety and effectiveness of the Q™ Revascularization System for the treatment […]
Tag: MIVI Neuroscience
MIVI Neuroscience Announces First-In-Man Series of The DAISe Clot Management System
EDEN PRAIRIE, Minn., June 29, 2018 /PRNewswire/ — MIVI Neuroscience, Inc. announced today it has successfully achieved first-in-man usage of the DAISe Clot Management System for next generation treatment of ischemic stroke. The proprietary DAISe Clot Management System is uniquely designed to remove […]
MIVI Neuroscience Begins European Commercialization After Achieving CE Mark Approval Of The R4Q Revascularization Catheter For Ischemic Stroke
EDEN PRAIRIE, Minn., March 29, 2018 /PRNewswire/ — MIVI Neuroscience, Inc. announced today it has received CE Mark approval for the R4Q Revascularization Catheter for the removal of fresh, soft emboli and thrombi in the peripheral and neurovascular systems. The CE Mark approval is […]